AlRest Medical

Noninvasive Bio-implants

Health Tech & Life Sciences
Non Active, Jan 2023 ceased to operate
Pre-Funding Rehovot Founded 2020
Total raised
Stage
Pre-Funding
Founded
2020
Headcount
6
HQ
Rehovot
Sector
Health Tech & Life Sciences

About

AlRest Medical has developed a solution for restoring articular cartilage in the knee using an acellular bioactive hydrogel scaffold. The injectable form of the product is designed to cover sites of any shape or size and affects only the cartilage, avoiding injury to the underlying bone and preventing patient suffering. The companys implant slowly releases a specific growth factor that mimics the bodys natural mechanisms, resulting in exceptional restoration of the defective cartilage. The results have been confirmed for both safety and efficacy in a six-month prospective study using a large animal model. AIRest Medicals innovative technique combined with its preclinical success may convince otherwise reluctant patients to reconsider treatment, enabling them to potentially benefit from a minimally invasive single procedure that could restore their native cartilage while offering a short recovery time.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is AlRest Medical's primary focus?
AlRest Medical focuses on developing noninvasive bio-implants, specifically a solution for restoring articular cartilage in the knee using an acellular bioactive hydrogel scaffold.
When was AlRest Medical founded?
AlRest Medical was founded in January 2020.
What is the current operational status of AlRest Medical?
AlRest Medical is currently inactive and ceased to operate in January 2023.
Where is AlRest Medical headquartered?
AlRest Medical is headquartered in Rehovot, Israel.
What is the core technology behind AlRest Medical's product?
AlRest Medical's core technology involves an injectable acellular bioactive hydrogel scaffold that slowly releases a specific growth factor to restore defective cartilage.
Has AlRest Medical's product undergone any preclinical studies?
Yes, the safety and efficacy of AlRest Medical's implant have been confirmed in a six-month prospective study using a large animal model.
What is AlRest Medical's current funding stage?
AlRest Medical is in the Pre-Funding stage, with a total raised amount of $0 USD.
How many employees did AlRest Medical have?
AlRest Medical had 6 employees.
Who is a key founder of AlRest Medical?
Ran Kapri is a founder of AlRest Medical.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B

Highlights

Verified

Tags

orthopedicsmedical-devicesmedical-technologiesminimally-invasiveregenerative-medicinesurgery